Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality.

@article{Harris2004PharmacokineticsAS,
  title={Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality.},
  author={Debra S. Harris and John E. Mendelson and EmilT. Lin and Robert A. Upton and Reese Jones},
  journal={Clinical pharmacokinetics},
  year={2004},
  volume={43 5},
  pages={
          329-40
        }
}
OBJECTIVE Buprenorphine and buprenorphine/naloxone combinations are effective pharmacotherapies for opioid dependence, but doses are considerably greater than analgesic doses. Because dose-related buprenorphine opioid agonist effects may plateau at higher doses, we evaluated the pharmacokinetics and pharmacodynamics of expected therapeutic doses. DESIGN The first experiment examined a range of sublingual buprenorphine solution doses with an ascending dose design (n = 12). The second… CONTINUE READING
BETA
Highly Cited
This paper has 64 citations. REVIEW CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 28 CITATIONS, ESTIMATED 44% COVERAGE

64 Citations

0510'07'10'13'16'19
Citations per Year
Semantic Scholar estimates that this publication has 64 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Opioid chronopharmacology [ letter ]

  • AW Fox
  • Cephalgia
  • 2001

A clinical trial of [abstract

  • WK Bickel, ML Stitzer, GE Bigelow
  • NIDA Res Monogr
  • 1999
2 Excerpts

Human pharmaco and liquid formulations

  • JJ Kuhlman, S Lalani, J Magluilo
  • Clin Pharmacol
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…